Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Biochem Biophys Res Commun ; 503(1): 8-13, 2018 09 03.
Article in English | MEDLINE | ID: mdl-29660344

ABSTRACT

Women with polycystic ovary syndrome (PCOS) are at increased risk of cardiovascular diseases (CVD); however, the independent role of PCOS in the incident CVD remains unknown. There are reports that hyperhomocysteinemia (HHcy), a potential cause of CVD, is frequently associated with PCOS. The present study investigates the independent attributes of hyperandrogenemia (HA), the integral associate of PCOS, and HHcy in causing atherogenic dyslipidemia. Twenty-five-day old rats were treated with homocysteine (Hcy) at 50 mg/kg/day dose level for 12 weeks. The HepG2 cell lines transfected with siRNA directed to PCSK9 were challenged with Hcy, homocysteine thiolactone (HTL), testosterone, 5α-dihydroxytestosterone (5α-DHT), or estradiol for 24 h. Rats administered with Hcy developed HHcy and displayed PCOS-like phenotypes with adversely altered lipid homeostasis and attenuated PI3K-AKT and Wnt signalling cascade. Overexpression of steroidogenic acute regulatory protein (StAR) and down-regulated expression of Aromatase together with elevated testosterone level marked the state of HA. In culture, the HepG2 cells responded independently to Hcy, HTL, testosterone, and 5α-DHT by an overt expression of PCSK9 and down-regulated expression of LDLR. The effect was magnified under the combined influence of Hcy and androgen(s). Estradiol, by contrast, exhibited the reverse effect. The findings suggest that HA may independently attribute to an increased cardiovascular risk in PCOS; however, the coexistence of HHcy catalyzes the risk further.


Subject(s)
Androgens/blood , Hyperhomocysteinemia/complications , Hyperhomocysteinemia/metabolism , Polycystic Ovary Syndrome/complications , Polycystic Ovary Syndrome/metabolism , Proprotein Convertase 9/metabolism , Receptors, LDL/metabolism , Animals , Cardiovascular Diseases/etiology , Cardiovascular Diseases/genetics , Cardiovascular Diseases/metabolism , Disease Models, Animal , Dyslipidemias/etiology , Dyslipidemias/metabolism , Female , Gene Expression , Hep G2 Cells , Humans , Lipid Metabolism , Metabolic Networks and Pathways , PCSK9 Inhibitors , Polycystic Ovary Syndrome/genetics , Proprotein Convertase 9/genetics , RNA, Small Interfering/genetics , Rats , Rats, Sprague-Dawley , Receptors, LDL/genetics , Risk Factors
2.
J Mol Neurosci ; 60(4): 421-435, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27665568

ABSTRACT

The neurodegeneration in colchicine induced AD rats (cAD) is mediated by cox-2 linked neuroinflammation. The importance of ROS in the inflammatory process in cAD has not been identified, which may be deciphered by blocking oxidative stress in this model by a well-known anti-oxidant vitamin C. Therefore, the present study was designed to investigate the role of vitamin C on colchicine induced oxidative stress linked neuroinflammation mediated neurodegeneration and memory impairments along with peripheral immune responses in cAD. The impairments of working and reference memory were associated with neuroinflammation and neurodegeneration in the hippocampus of cAD. Administration of vitamin C (200 and 400 mg/kg BW) in cAD resulted in recovery of memory impairments, with prevention of neurodegeneration and neuroinflammation in the hippocampus. The neuroinflammation in the hippocampus also influenced the peripheral immune responses and inflammation in the serum of cAD and all of these parameters were also recovered at 200 and 400 mg dose of vitamin C. However, cAD treated with 600 mg dose did not recover but resulted in increase of memory impairments, neurodegeneration and neuroinflammation in hippocampus along with alteration of peripheral immune responses in comparison to cAD of the present study. Therefore, the present study showed that ROS played an important role in the colchicine induced neuroinflammation linked neurodegeneration and memory impairments along with alteration of peripheral immune responses. It also appears from the results that vitamin C at lower doses showed anti-oxidant effect and at higher dose resulted in pro-oxidant effects in cAD.


Subject(s)
Alzheimer Disease/drug therapy , Anti-Inflammatory Agents/therapeutic use , Ascorbic Acid/therapeutic use , Memory/drug effects , Vitamins/therapeutic use , Alzheimer Disease/etiology , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/pharmacology , Ascorbic Acid/administration & dosage , Ascorbic Acid/pharmacology , Colchicine/toxicity , Hippocampus/drug effects , Hippocampus/metabolism , Inflammation/drug therapy , Male , Mice , Oxidative Stress , Rats , Reactive Oxygen Species/metabolism , Vitamins/administration & dosage , Vitamins/pharmacology
3.
Reproduction ; 151(6): 693-707, 2016 06.
Article in English | MEDLINE | ID: mdl-27026713

ABSTRACT

Puerarin, a selective oestrogen receptor modulator, intercepts implantation in rats, albeit at unacceptably higher doses. We developed poly lactic-co-glycolic acid-encapsulated nano-puerarin (PN) and mapped the molecular pathway underlying its anti-implantation effects. Smooth-surfaced and spherical PN having a mean diameter of ∼147nm was obtained with good yield, efficient encapsulation, and optimum drug loading. In culture, PN slowly and steadily released puerarin, which was readily taken up by the decidual cells. PN exerted a dose-dependent anti-implantation effect. As marked by attenuated expression of stromal cell desmin, alkaline phosphatase, IGFBP1, and decidual prolactin-related protein, the anti-implantation effect of PN seemed secondary to compromised decidualization. Using in vivo (pregnant and pseudopregnant rats) and in vitro (endometrial stromal cell culture) treatment models, we document that PN enforced inhibition of uterine expression of Hbegf and Hoxa10 and their downstream signalling molecules, Cyclin D3 (CCND3)/CDK4. PN also efficiently ablated the Ihh-Nr2f2-Bmp2 signalling pathway and invited the loss of uterine potential for decidualization. There was a dose-dependent up-regulation of RHOA and its effector protein kinase, ROCK1, leading to the promotion of MLC phosphorylation and actin-myosin interaction. PN also down-regulated the stromal cell activation of ERK½ and expression of MMP9. These effects acting together stabilized the stroma and inhibited the stromal cell migration. Central to this array of events was the adversely altered endometrial expression of oestrogen receptor subtypes and repression of progesterone receptor that indulged endless proliferation of luminal epithelia and distorted the precisely choreographed stroma-epithelia crosstalk. Thus, PN dismantles the endometrial bed preparation and prevents implantation.


Subject(s)
Contraceptive Agents/pharmacology , Embryo Implantation/drug effects , Fertility/drug effects , Isoflavones/pharmacology , Nanoparticles/chemistry , Animals , Cells, Cultured , Contraceptive Agents/administration & dosage , Decidua/drug effects , Decidua/physiology , Female , Isoflavones/administration & dosage , Male , Nanoparticles/administration & dosage , Pregnancy , Rats , Rats, Sprague-Dawley , Stromal Cells/cytology , Stromal Cells/drug effects , Uterus/cytology , Uterus/drug effects , Vasodilator Agents/administration & dosage , Vasodilator Agents/pharmacology
4.
PLoS One ; 9(5): e96210, 2014.
Article in English | MEDLINE | ID: mdl-24788203

ABSTRACT

The ovary receives a finite pool of follicles during fetal life. Atresia remains the major form of follicular expenditure at all stages since development of ovary. The follicular reserve, however, declines at an exponential rate leading to accelerated rate of decay during the years preceding menopause. We examined if diminished follicle reserve that characterizes ovarian aging impacts the attrition rate. Premature ovarian aging was induced in rats by intra-embryonic injection of galactosyltransferase-antibody on embryonic day 10. On post-natal day 35 of the female litters, either a wedge of fat (sham control) or a wild type ovary collected from 25-day old control rats, was transplanted under the ovarian bursa in both sides. Follicular growth and atresia, and ovarian microenvironment were evaluated in the follicle-deficient host ovary and transplanted ovary by real time RT-PCR analysis of growth differentiation factor-9, bone morphogenetic protein 15, and kit ligand, biochemical evaluation of ovarian lipid peroxidation, superoxide dismutase (SOD) and catalase activity, and western blot analysis of ovarian pro- and anti-apoptotic factors including p53, bax, bcl2, and caspase 3. Results demonstrated that the rate of follicular atresia, which was highly preponderant in the follicle-deficient ovary of the sham-operated group, was significantly prevented in the presence of the transplanted ovary. As against the follicle-deficient ovary of the sham-operated group, the follicle-deficient host ovary as well as the transplanted ovary in the ovary-transplanted group exhibited stimulated follicle growth with increased expression of anti-apoptotic factors and down regulation of pro-apoptotic factors. Both the host and transplanted ovaries also had significantly lower rate of lipid peroxidation with increased SOD and catalase activity. We conclude that the declining follicular reserve is perhaps the immediate thrust that increases the rate of follicle depletion during the final phase of ovarian life when the follicle reserve wanes below certain threshold size.


Subject(s)
Aging/physiology , Follicular Atresia/physiology , Ovary/physiology , Reproduction/physiology , Animals , Apoptosis/physiology , Bone Morphogenetic Protein 15/genetics , Caspase 3/metabolism , Catalase/genetics , Catalase/metabolism , Female , Follicular Atresia/genetics , Follicular Atresia/metabolism , Gene Expression , Granulosa Cells/metabolism , Granulosa Cells/physiology , Growth Differentiation Factor 9/genetics , Immunoblotting , Lipid Peroxidation , Microscopy, Confocal , Ovarian Follicle/metabolism , Ovarian Follicle/physiology , Ovary/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Stem Cell Factor/genetics , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Time Factors , bcl-2-Associated X Protein/metabolism
5.
Toxicol Appl Pharmacol ; 277(1): 95-107, 2014 May 15.
Article in English | MEDLINE | ID: mdl-24675710

ABSTRACT

Three phenolic glycosides isolated from the heartwood of Pterocarpus marsupium showed significant free radical and superoxide ion scavenging activity and antioxidant potential that were comparable to, or several folds higher than those of standard antioxidants, trolox and ascorbic acid. The effective concentrations of these compounds were far below their cytotoxic levels. Compound 3, which was characterized to be α-dihydroxychalcone-glycoside (α-DHC), was the most potent one. Subsequent studies demonstrated that α-DHC effectively reduced nitric oxide and cytokine production by the LPS stimulated RAW 264.7 mouse macrophage cell line. The compound effectively attenuated the expression of inflammation-mediating enzymes COX-2 and iNOS at the mRNA as well as protein levels in a concentration dependent manner. It prevented phosphorylation of all the three MAPKs (JNK, ERK, p38) and eventually blocked the activation of downstream elements contributing to inflammation. Phosphorylation of IκB-α and subsequent translocation of NF-κB into the nucleus were restricted, while the expression of stress responsive gene HO-1 was up-regulated. α-DHC targeted Keap-1 by modifying its cysteine thiols, dissociating it from Nrf-2 and facilitating nuclear entry of the latter; and this in turn induced HO-1 expression. Thus α-DHC exerts its anti-inflammatory activity in a dual manner: by down regulating MAPKs and restricting nuclear stabilization of NF-κB at one end, and by disrupting Nrf-2-Keap-1 complex on the other. In conclusion, the anti-inflammatory potential together with its high therapeutic index envisages α-DHC as a prospective candidate molecule for the development of therapeutic strategy against inflammatory disorders.


Subject(s)
Free Radical Scavengers/metabolism , Glycosides/pharmacology , Inflammation Mediators/metabolism , Macrophages/metabolism , Pterocarpus , Animals , Antioxidants/metabolism , Blotting, Western , Cell Line , Cell Survival , Cytokines/metabolism , Dose-Response Relationship, Drug , Down-Regulation , Lipopolysaccharides/toxicity , Macrophages/drug effects , Mice , Mitogen-Activated Protein Kinases/metabolism , Plant Extracts , Polymerase Chain Reaction , Up-Regulation
6.
PLoS One ; 8(9): e74155, 2013.
Article in English | MEDLINE | ID: mdl-24040195

ABSTRACT

The management of recurrent pregnancy loss (RPL) still remains a great challenge, and women with polycystic ovarian syndrome (PCOS) are at a greater risk for spontaneous abortion. Treatment with low-molecular-weight heparin (LMWH) has become an accepted treatment option for women with RPL; however, the subgroup of women, who are likely to respond to LMWH, has not been precisely identified. The present study evaluated the efficacy of LMWH with reference to PCOS and associated metabolic phenotypes including hyperhomocysteinemia (HHcy), insulin resistance (IR) and obesity. This prospective observational study was conducted at Institute of Reproductive Medicine, Kolkata, India. A total of 967 women with history of 2 or more consecutive first trimester abortions were screened and 336 were selected for the study. The selected patients were initially divided on the basis of presence or absence of PCOS, while subsequent stratification was based on HHcy, IR and/or obesity. The subjects had treatment with aspirin during one conception cycle and aspirin-LMWH combined anticoagulant therapy for the immediate next conception cycle, if the first treated cycle was unsuccessful. Pregnancy salvage was the sole outcome measure. The overall rate of pregnancy salvage following aspirin therapy was 43.15%, which was mostly represented by normohomocysteinemic women, while the salvage rate was lower in the HHcy populations irrespective of the presence or absence of PCOS, IR, or obesity. By contrast, aspirin-LMWH combined therapy could rescue 66.84% pregnancies in the aspirin-failed cases. Logistic regression analyses showed that HHcy remained a significant factor in predicting salvage rates in the PCOS, IR, and obese subpopulations controlled for other confounding factors. With regard to pregnancy salvage, combined anticoagulant therapy with aspirin and LMWH conferred added benefit to those with HHcy phenotype.


Subject(s)
Abortion, Habitual/drug therapy , Anticoagulants/therapeutic use , Aspirin/therapeutic use , Heparin, Low-Molecular-Weight/therapeutic use , Hyperhomocysteinemia/drug therapy , Obesity/drug therapy , Polycystic Ovary Syndrome/drug therapy , Abortion, Habitual/pathology , Adult , Drug Therapy, Combination , Female , Humans , Hyperhomocysteinemia/complications , Hyperhomocysteinemia/pathology , Insulin Resistance , Live Birth , Obesity/complications , Obesity/pathology , Polycystic Ovary Syndrome/complications , Polycystic Ovary Syndrome/pathology , Pregnancy , Prospective Studies , Risk Factors , Treatment Outcome
7.
Pharm Biol ; 51(11): 1363-71, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23859609

ABSTRACT

CONTEXT: The detrimental effects of arsenic on female reproductive functions may involve overt oxidative stress. Casein and pea [Pisum sativum Linn. (Fabaceae)] proteins have antioxidant properties. OBJECTIVE: To investigate the role of casein- and pea-supplemented high-protein diet (HPD) in utero-ovarian protection from arsenic toxicity. MATERIALS AND METHODS: Adult female Wistar rats were orally gavaged with vehicle (Gr-I) or arsenic at 3 ppm/rat/d (Gr-II and Gr-III) for 30 consecutive days, when they were maintained on either regular diet containing 18% protein (Gr-I and Gr-II), or HPD containing 27% protein in the form of casein (20%) and pea (7%) (Gr-III). Reproductive functions were evaluated using a battery of biochemical and histological techniques. RESULTS: As compared to Gr-I, the Gr-II rats suffered from loss of estrous cyclicity, reduction in weight (mg/100 g body weight) of ovary (Gr-I: 54.3 ± 4.2 versus Gr-II: 35.8 ± 1.6; p < 0.001) and uterus (Gr-I: 161.7 ± 24.6 versus Gr-II: 94.44 ± 13.2; p < 0.05), utero-ovarian degeneration, attenuated ovarian activities (unit/mg tissue/h) of Δ(5), 3ß-hydroxysteroid dehydrogenase (Gr-I: 3.41 ± 0.12 versus Gr-II: 2.31 ± 0.09; p < 0.01) and 17ß-hydroxysteroid dehydrogenase (Gr-I: 3.82 ± 0.57 versus Gr-II: 1.24 ± 0.19; p < 0.001), and decreased serum estradiol level (pg/ml) (Gr-I: 61.5 ± 2.06 versus 34.1 ± 2.34; p < 0.001). Ovarian DNA damage was preponderant with blatant generation of malondialdehyde (nM/mg tissue; Gr-I: 15.10 ± 2.45 versus Gr-II: 29.51 ± 3.44; p < 0.01) and attenuated superoxide dismutase activity (unit/mg tissue) (Gr-I: 2.18 ± 0.19 versus Gr-II: 1.33 ± 0.18; p < 0.05). The Gr-III rats were significantly protected from these ill effects of arsenic. DISCUSSION AND CONCLUSION: HPD, by way of antioxidant properties, may find prospective role in the protection of reproductive damage caused by arsenic.


Subject(s)
Caseins/administration & dosage , Environmental Pollutants/toxicity , Ovary/drug effects , Oxides/toxicity , Pisum sativum , Plant Proteins, Dietary/administration & dosage , Reproduction/drug effects , Uterus/drug effects , 17-Hydroxysteroid Dehydrogenases/metabolism , 3-Hydroxysteroid Dehydrogenases/metabolism , Animal Feed , Animals , Arsenic Trioxide , Arsenicals , Body Weight , Cytoprotection , DNA Damage , Eating , Estradiol/blood , Estrous Cycle/drug effects , Female , Malondialdehyde/metabolism , Organ Size , Ovary/metabolism , Ovary/pathology , Ovary/physiopathology , Oxidative Stress , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Uterus/metabolism , Uterus/pathology , Uterus/physiopathology
8.
PLoS One ; 8(5): e64446, 2013.
Article in English | MEDLINE | ID: mdl-23700477

ABSTRACT

Recurrent pregnancy loss (RPL) in polycystic ovary syndrome (PCOS), which occurs in ∼50% of total pregnancies is a frequent obstetric complication. Among the several hypotheses, insulin resistance (IR), obesity and hyperhomocysteinemia (HHcy) play significant role/s in RPL. This study was conducted to assess the link between elevated levels of homocysteine and IR in PCOS-associated women with RPL in Kolkata, India. A retrospective study was conducted of one hundred and twenty six PCOS women (<30 years) who experienced two or more spontaneous abortions during the first trimester presenting to Institute of Reproductive Medicine (IRM) in Kolkata during the period of March 2008 through February 2011. One hundred and seventeen non-PCOS subjects with matching age range were randomly chosen as controls. Incidence of HHcy and IR was 70.63% (n = 89) and 56.34% (n = 71), respectively, in RPL-affected PCOS population which was significantly higher (p<0.04; p<0.0001) when compared to the non-PCOS set (HHcy: 57.26%; IR: 6.83%). Rates of miscarriage were significantly higher (p<0.008; p<0.03) in hyperhomocysteinemia-induced miscarriage when compared to the normohomocysteinemic segment (PCOS: 70.63% vs.29.36% & non-PCOS: 57.26% vs. 42.73%) along with the insulin resistant (p<0.04; p<0.0001) population (PCOS: 70.63% vs. 56.34% & non-PCOS: 57.26% vs. 6.83%) in both groups. A probabilistic causal model evaluated HHcy as the strongest plausible factor for diagnosis of RPL. A probability percentage of 43.32% in the cases of HHcy- mediated RPL suggests its increased tendency when compared to IR mediated miscarriage (37.29%), further supported by ROC-AUC (HHcy: 0.778vs. IR: 0.601) values. Greater susceptibility towards HHcy may increase the incidence for miscarriage in women in India and highlights the need to combat the condition in RPL control programs in the subcontinent.


Subject(s)
Abortion, Habitual/etiology , Polycystic Ovary Syndrome/complications , Polycystic Ovary Syndrome/metabolism , Adult , Female , Humans , Hyperhomocysteinemia/complications , Hyperhomocysteinemia/metabolism , Insulin Resistance , Pregnancy , Prognosis , ROC Curve , Retrospective Studies , Risk Factors , Young Adult
9.
Biol Trace Elem Res ; 152(1): 9-15, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23322284

ABSTRACT

Insulin resistance is a very common associate of polycystic ovary syndrome (PCOS). Pathophysiology in relation with the essential elements including copper, magnesium, zinc, manganese, chromium, and calcium has been reported in women with insulin resistance. This prospective study was designed to explore whether the women with PCOS do exhibit altered serum element levels in association with/without insulin resistance. One hundred and thirty-two women with PCOS and forty-six control women were studied. Women with PCOS were further divided based on the presence of insulin resistance (insulin resistant: n = 50; non-insulin resistant: n = 82). In all women, basal levels of gonadotropins, prolactin, testosterone, insulin, glucose, and the six different elements were measured. Serum levels of testosterone (p < 0.001), luteinizing hormone (p < 0.05), and fasting insulin (p < 0.004) were significantly higher in the PCOS population compared to controls as well as PCOS women without insulin resistance. Women with PCOS exhibited a significantly high calcium (p < 0.04) and lower manganese levels (p < 0.002) when compared to controls. However, the PCOS women with insulin resistance exhibited significantly lower serum levels of magnesium and chromium (p < 0.04), in addition to higher levels of zinc and copper (p < 0.04). The differences in calcium (p < 0.03) and manganese levels (p < 0.0001) became aggravated with the presence of insulin resistance when compared to control as well as PCOS women without insulin resistance. In PCOS-associated insulin resistance, circulating serum magnesium (r = -0.31; p < 0.03) and chromium (r = -0.38; p < 0.006) status significantly correlated with fasting insulin levels. We conclude that imbalanced element status may be a key foundation for insulin resistance in PCOS. The findings in this study should be investigated with further trials in order to obtain new insights into PCOS.


Subject(s)
Insulin Resistance , Polycystic Ovary Syndrome/blood , Trace Elements/blood , Adult , Blood Glucose/analysis , Calcium/blood , Chromium/blood , Copper/blood , Fasting/blood , Female , Gonadotropins/blood , Humans , Insulin/blood , Luteinizing Hormone/blood , Magnesium/blood , Manganese/blood , Polycystic Ovary Syndrome/physiopathology , Prolactin/blood , Prospective Studies , Testosterone/blood , Zinc/blood
10.
Reproduction ; 144(5): 633-45, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22919047

ABSTRACT

The tubers of Pueraria tuberosa have folkloric repute as emmenagogue. The n-BuOH fraction of the ethanolic extract of tubers exhibits significant antifertility activity in laboratory animals. The present investigation explored the active principle(s) of the tuber extract with reference to contragestive effects in rats and probed the possible mechanism of action. Bioactivity-guided fractionation identified puerarin as the major constituent that exerted pregnancy-terminating effects. Oral administration of puerarin at ≥300  mg/kg per day for days (D) 1-2 post-coitus resulted in complete implantation failure. Serum oestradiol levels during D2-D5 and progesterone (P(4)) level on D5 remained unaffected, but the endometrial expression of oestrogen receptor α (ERα) and ERß was adversely modulated that disrupted the implantation-specific characteristic endometrial oestrogenic milieu. The eventual consequence was loss of endometrial receptivity characterised by down-regulation of the uterine expression of P(4) receptor (PR) and attenuation of endometrial expression of leukaemia inhibitory factor, vascular endothelial growth factor and cyclo-oxygenase-2, the three important signalling molecules involved in the process of implantation. Light microscopic examination of the embryos demonstrated no untoward effect of puerarin on the development of embryos until D4, but D5 blastocysts underwent gross morphological distortion. The findings taken together are interpreted to suggest that puerarin adversely impacts the uterine expression of ER and PR that disrupts the implantation-conducive uterine milieu and prevents implantation. In conclusion, puerarin may be envisaged as a prospective molecule that merits further exploration for the development of non-steroidal post-coital contraceptive for women.


Subject(s)
Embryo Implantation/drug effects , Isoflavones/pharmacology , Selective Estrogen Receptor Modulators/pharmacology , Animals , Contraceptives, Postcoital , Cyclooxygenase 2/analysis , Endometrium/drug effects , Endometrium/physiology , Estradiol/blood , Estrogen Receptor alpha/genetics , Estrogen Receptor beta/genetics , Female , Gene Expression/drug effects , Isoflavones/administration & dosage , Leukemia Inhibitory Factor/analysis , Pregnancy , Progesterone/blood , Rats , Time Factors , Uterus/chemistry , Vascular Endothelial Growth Factor A/analysis
11.
PLoS One ; 7(2): e30709, 2012.
Article in English | MEDLINE | ID: mdl-22319579

ABSTRACT

Clinical evidence suggests an association between galactosaemia and premature ovarian insufficiency (POI); however, the mechanism still remains unresolved. Experimental galactose toxicity in rats produces an array of ovarian dysfunction including ovarian development with deficient follicular reserve and follicular resistance to gonadotrophins that characterize the basic tenets of human POI. The present investigation explores if galactose toxicity in rats attenuates the bioactivity of gonadotrophins or interferes with their receptor competency, and accelerates the rate of follicular atresia. Pregnant rats were fed isocaloric food-pellets supplemented with or without 35% D-galactose from day-3 of gestation and continuing through weaning of the litters. The 35-day old female litters were autopsied. Serum galactose-binding capacity, galactosyltransferase (GalTase) activity, and bioactivity of FSH and LH together with their receptor competency were assessed. Ovarian follicular atresia was evaluated in situ by TUNEL. The in vitro effects of galactose were studied in isolated whole follicles in respect of generation of reactive oxygen species (ROS) and expression of caspase 3, and in isolated granulosa cells in respect of mitochondrial membrane potential, expression of p53, and apoptosis. The rats prenatally exposed to galactose exhibited significantly decreased serum GalTase activity and greater degree of galactose-incorporation capacity of sera proteins. LH biopotency and LH-FSH receptor competency were comparable between the control and study population, but the latter group showed significantly attenuated FSH bioactivity and increased rate of follicular atresia. In culture, galactose increased follicular generation of ROS and expression of caspase 3. In isolated granulosa cells, galactose disrupted mitochondrial membrane potential, stimulated p53 expression, and induced apoptosis in vitro; however co-treatment with either FSH or estradiol significantly prevented galactose-induced granulosa cell p53 expression. We conclude that the ovotoxic effects of galactose involves attenuation of FSH bioactivity that renders the ovary resistant to gonadotrophins leading to increased granulosa cell expression of p53 and follicular atresia.


Subject(s)
Follicle Stimulating Hormone/antagonists & inhibitors , Galactose/toxicity , Granulosa Cells/metabolism , Tumor Suppressor Protein p53/biosynthesis , Animals , Female , Follicle Stimulating Hormone/metabolism , Follicular Atresia , Gonadotropins , Humans , In Situ Nick-End Labeling , Pregnancy , Rats , Up-Regulation/drug effects
12.
Reprod Biomed Online ; 20(1): 103-13, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20158995

ABSTRACT

Of the variety of contraceptive options available for women, very few provide dual protection against sexually transmitted diseases. Due to increased incidence of human immunodeficiency virus type 1 (HIV-1), genital herpes, hepatitis B and human papilloma virus, development of novel contraceptive strategies that incorporate antiviral activity has become the top priority in contraceptive research. Topical microbicides are now considered to be the last ray of hope, as they would ideally provide protection against unwanted pregnancy, proper lubrication during sexual activity, and preclude the vaginal/rectal transmission of sexually transmitted diseases. A large number of vaginal microbicides are in the preclinical or clinical stages of evaluation for their safety, efficacy and acceptability. However, a major bottleneck in the development of novel mechanism-based dual microbicides has been their detergent-like effects, along with debilitating action on the vaginal microflora. Hence the search is still on for the ideal dual microbicide/s that may obliterate these disadvantages and provide an invincible shield to women in their crusade against unintended pregnancy as well as sexually transmitted diseases. The present review highlights the current scenario towards the development of novel contraceptive strategies to counteract the rampant spread of sexually transmitted diseases, with special reference to HIV/AIDS.


Subject(s)
Anti-Infective Agents, Local/therapeutic use , Contraception/trends , Sexually Transmitted Diseases/prevention & control , Antiviral Agents/therapeutic use , Contraception/methods , Female , HIV Infections/prevention & control , Humans , Male , Pregnancy , Pregnancy, Unwanted
13.
Reproduction ; 138(3): 453-62, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19703946

ABSTRACT

As a part of our continued venture to develop a safe and effective spermicide, we have identified a triterpene glycoside (Acaciaside-B (Ac-B))-enriched fraction (Ac-B-en) isolated from the seeds of Acacia auriculiformis and evaluated its spermicidal potential in vitro. Sperm motility was completely inhibited within 20 s at a minimum effective concentration (MEC) of 120 microg/ml. Tests for sperm viability by dual fluoroprobe staining showed the effect to be spermicidal with an EC(50) of 35.20 microg/ml. A series of investigations including tests for hypo-osmotic swelling, membrane lipid peroxidation, and electron microscopy document that the spermicidal effect of the fraction involves loss of sperm plasma membrane integrity and dissolution of the acrosomal vesicle--the two most important structural components that play diverse roles in physiological functions of sperm including fertilization. The fraction at 10 x MEC exerted no detrimental effects on in vitro growth of Lactobacillus acidophilus, which is considered the major constituent of vaginal microflora that maintains vaginal health. Ames tests performed with different strains of Salmonella typhimurium including TA 97a, 98, 100, and 102, which detect mutagens causing bp substitution or frameshifting at G-C or A-T bp, demonstrate no mutagenic potential of the fraction. Significant spermicidal potential with no possible mutagenic effect and adverse impacts on lactobacilli growth attests to the credential of Ac-B-en as a prospective future spermicide for the development of a safe and effective vaginal contraceptive formulation.


Subject(s)
Acacia/chemistry , Saponins/pharmacology , Spermatocidal Agents/adverse effects , Spermatocidal Agents/pharmacology , Triterpenes/pharmacology , Cell Survival/drug effects , Drug Discovery , Drug Evaluation, Preclinical , Humans , Lactobacillus acidophilus/drug effects , Lactobacillus acidophilus/growth & development , Lactobacillus acidophilus/physiology , Lipid Peroxidation/drug effects , Male , Mutagenicity Tests , Mutation/drug effects , Plant Extracts/adverse effects , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Saponins/adverse effects , Saponins/chemistry , Saponins/isolation & purification , Sperm Motility/drug effects , Spermatocidal Agents/chemistry , Spermatocidal Agents/isolation & purification , Spermatozoa/drug effects , Spermatozoa/metabolism , Spermatozoa/physiology , Spermatozoa/ultrastructure , Triterpenes/adverse effects , Triterpenes/chemistry , Triterpenes/isolation & purification
14.
J Clin Immunol ; 29(5): 582-94, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19513820

ABSTRACT

INTRODUCTION: Owing to the established roles of human macrophages in immune defense, we investigated the effect of chronic arsenic exposure upon these major hematopoietic cells in 70 arsenic-exposed individuals with skin lesions and 64 unexposed individuals. METHODS: Human monocyte-derived macrophages were prepared from peripheral blood mononuclear cells, by culture of the adherent cells for 6 days in medium supplemented with granulocyte-monocyte colony stimulating factor. Parameters studied included cell adhesion capacity, expression of CD54 and F-actin, nitric oxide production, phagocytic capacity, and effect of arsenic on Rho A-ROCK pathway. RESULTS: In macrophages of exposed individuals when compared to unexposed group, there was cell rounding accompanied with a significant (p < 0.001) loss of cell adhesion capacity, decrease in nitric oxide production, impaired phagocytic capacity, and decreased CD 54 and F-actin expression. Additionally, chronic arsenic exposure affected Rho A-ROCK pathway which in turn impaired macrophage functions. DISCUSSION AND CONCLUSION: These altogether could contribute significantly to arsenic-induced immunosuppression observed in the arsenic-exposed individuals.


Subject(s)
Arsenic/toxicity , Macrophages/drug effects , Skin Diseases/immunology , Actins/genetics , Actins/immunology , Actins/metabolism , Adolescent , Adult , Aged , Amides/pharmacology , Arsenic/administration & dosage , Arsenic/urine , Cell Adhesion/drug effects , Cell Adhesion/immunology , Cells, Cultured , Environmental Exposure/adverse effects , Female , GTP-Binding Protein alpha Subunits/metabolism , Humans , Immunosuppression Therapy , Intercellular Adhesion Molecule-1/genetics , Intercellular Adhesion Molecule-1/immunology , Intercellular Adhesion Molecule-1/metabolism , Macrophages/immunology , Macrophages/metabolism , Macrophages/pathology , Male , Middle Aged , Nitric Oxide/metabolism , Occupational Exposure/adverse effects , Phagocytosis/drug effects , Phagocytosis/immunology , Pyridines/pharmacology , Skin/drug effects , Skin/immunology , Skin/metabolism , Skin/pathology , Skin Diseases/chemically induced , Water/chemistry , rho-Associated Kinases/metabolism
15.
Contraception ; 77(6): 456-62, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18477497

ABSTRACT

BACKGROUND: This study was conducted for to explore the plausible pathway of Chenopodium album seed extract (CAE)-mediated sperm cell death. STUDY DESIGN: The role of CAE for its spermicidal action was assessed by (a) measuring lipid peroxidation, protein carbonyl content and intracellular glutathione content in CAE exposed sperm cells; (b) assaying antioxidant enzymes like catalase and superoxide dismutase (SOD); (c) analyzing protein expressions by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot analysis; (d) fluorimetric measurement of intracellular H(2)O(2) level and generation of reactive oxygen species (ROS) in CAE-treated sperm cells; and (e) DNA ladder formation study. RESULTS: CAE-induced sperm death is due to (a) lipid peroxidation of the sperm cell membrane, oxidation of some critical cellular proteins and depletion of intracellular reduced gluthathione, indicating production of ROS; (b) activation of Mn-SOD and inactivation of catalase favoring endogenous accumulation of H(2)O(2); (c) generation of O(2)(*-) at an enhanced rate during oxidative stress as evidenced by increased Mn-SOD activity and protein expression; (d) accumulation of ROS in spermatozoa reflected in the fluorimetric experiments; and (e) increased production of O(2)(*-) and H(2)O(2) induced apoptosis-like death in sperm cells as observed by DNA ladder formation. CONCLUSION: The sperm death mediated by CAE is due to oxidative damage of cellular macromolecules by in situ generation of ROS.


Subject(s)
Cell Death , Chenopodium album , Plant Extracts/pharmacology , Seeds , Spermatocidal Agents/pharmacology , Spermatozoa/drug effects , Spermatozoa/pathology , Animals , Catalase/metabolism , DNA Fragmentation , Glutathione/metabolism , Lipid Peroxidation , Male , Peroxidases/metabolism , Protein Carbonylation , Rats , Rats, Sprague-Dawley , Spermatozoa/metabolism , Superoxide Dismutase/metabolism
16.
Contraception ; 75(1): 71-8, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17161128

ABSTRACT

PURPOSE: Aqueous decoction of Chenopodium album seeds (CAD) was assessed for its sperm-immobilizing and contraceptive efficacy in laboratory mammals. METHOD: Spermicidal efficacy was evaluated in vitro by a modified Sander-Cramer test. The mode of spermicidal action was assessed by (a) supravital and double fluoroprobe staining of sperm, (b) hypoosmotic swelling tests and (c) transmission electron microscopy. Contraceptive efficacy was evaluated by intrauterine and vaginal application of CAD in rats and rabbits, respectively, followed by their mating and evaluation of pregnancy outcomes. RESULTS: The minimum effective concentration of CAD that induced instantaneous immobilization of rat spermatozoa in vitro was 2 mg/mL. The mechanism of CAD action involved disintegration of sperm plasma membrane and dissolution of acrosomal cap causing sperm death. Fertilization of oocytes and establishment of implantation were prevented in the uterine horn that was administered with CAD, while these events occurred unhindered in the untreated contralateral side. In rabbit, intravaginal application of CAD significantly blocked the establishment of pregnancy. CONCLUSION: CAD possesses appreciable spermicidal potential, which may be explored as an effector constituent of vaginal contraceptive.


Subject(s)
Chenopodium album/chemistry , Contraception/methods , Plant Extracts/pharmacology , Sperm Motility/drug effects , Sperm-Ovum Interactions/drug effects , Spermatocidal Agents/pharmacology , Animals , Dose-Response Relationship, Drug , Female , Male , Pregnancy , Pregnancy Rate , Rabbits , Rats , Seeds , Sperm Head/drug effects , Spermatozoa/drug effects , Spermatozoa/physiology , Treatment Outcome
17.
Biol Reprod ; 71(6): 1822-7, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15286041

ABSTRACT

The precise cellular mechanism of primordial germ cell (PGC) migration remains unknown. Cell surface galactosyltransferase (GalTase) is known to play unique roles in the process of locomotion of many migratory cells. With an objective to seek evidence for possible involvement of GalTase in the migratory process of PGC, we evaluated germ cell migration in the rat following experimental modulation of embryonic GalTase activity. Pregnant rats were laparotomized under anesthesia on Day 10 of pregnancy. While embryos of one uterine horn received lysozyme (100 microg/fetus), those of the other received alpha-lactalbumin (LA; 100 microg/fetus), N-acetylglucosamine (GlcNAc; 250 nmole/fetus), uridine 5'-monophosphate (UMP; 2.5 micromole/fetus), uridine diphosphate-galactose (UDP-gal; 250 nmole/fetus), or a combination of 250 nmole of UDP-gal and 2.5 micromole of UMP/fetus. Between gestation Days 12 and 14, embryos were dissected out and processed for histochemical localization of PGC on the basis of binding of Dolichos biflorus agglutinin on the surface glycoconjugate of the germ cells. The number of PGC in each embryo was counted. There was a daywise increase in the number of PGC in all groups. As compared with lysozyme-exposed controls, the numbers of PGCs at the day-specific sites on all days of examination were significantly lower in the LA- as well as GlcNAc-exposed groups. UMP or UDP-gal individually exerted little or no influence, while the total PGC count rose significantly over the respective control values under simultaneous exposure to UMP and UDP-gal. The present findings suggest a likely catalytic role of GalTase in the process of germ cell migration.


Subject(s)
Cell Movement/physiology , Galactosyltransferases/physiology , Germ Cells/physiology , Gonads/embryology , Acetylglucosamine/pharmacology , Animals , Cell Count , Cell Movement/drug effects , Drug Combinations , Embryo, Mammalian/cytology , Female , Galactosyltransferases/drug effects , Gestational Age , Lactalbumin/pharmacology , Pregnancy , Rats , Rats, Sprague-Dawley , Uridine Diphosphate Galactose/pharmacology , Uridine Monophosphate/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...